Local Oestrogen Treatment in Postmenopausal Women Undergoing Pelvic Organ Prolapse Surgery (LOTUS) - Feasibility Study

Trial Profile

Local Oestrogen Treatment in Postmenopausal Women Undergoing Pelvic Organ Prolapse Surgery (LOTUS) - Feasibility Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Estradiol (Primary)
  • Indications Menopausal syndrome
  • Focus Therapeutic Use
  • Acronyms LOTUS
  • Most Recent Events

    • 05 Nov 2015 Planned End Date changed from 28 Mar 2017 to 1 Jul 2017 as reported by United Kingdom Clinical Research Network record.
    • 05 Nov 2015 Accrual to date is 34%, according to United Kingdom Clinical Research Network record.
    • 05 Nov 2015 Accrual to date is 25%, according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top